CBE, CNSI, CSEP, GSDS, OFFICE OF DEVELOPMENT-PARENT FUND, AND WISE PRESENT A CAREER TALK PRESENTS A SEMINAR: Joon Bok Lee, Ph.D., Analytics Algorithms Engineer, Insulet Corporation
Current Topics in Bioengineering Career Talk
Thursday, January 19, 2017
2:00 - 3:00 pm
*Light refreshments will be provided*
Joon Bok Lee, Ph.D.
Analytics Algorithms Engineer
Journey of the Artificial Pancreas: From Graduate School to Industry
Control of blood glucose concentrations in people with Type 1 Diabetes Mellitus (T1DM) is a challenging task. Millions of T1DM patients suffer from the effects of dangerously high or low glucose levels every day. Principles of process dynamics and control play a critical role in the design of an artificial pancreas (AP), a device that can automate this regulation of blood glucose and significantly reduce the dangers faced by people with T1DM. In this talk, I will present a brief overview of the histories and motivations behind this research, and how Insulet is developing AP technology upon innovations originated from academia. I will describe how my current position as analytics algorithms contributes to the development of both the closed-loop algorithm and the infrastructures that surround the AP system. I will also share my personal journey from graduate school to the industry, and discuss insights and advice I gained during this process that may be also helpful to other graduate students and researchers who are considering career options.
Biography: Dr. Joon Bok Lee is currently an Analytics/Algorithms Engineer at Insulet Corporation located in Billerica, MA. He is the technical leader in the development of glucose control algorithms for the company’s first generation of Artificial Pancreas device. Dr. Lee received his Ph.D. in Chemical Engineering from the University of California, Santa Barbara in 2016. His research interests are in applications of the principles of process dynamics and control in the field of artificial pancreas. Dr. Lee has multiple peer-reviewed publications and thousands of hours of experience conducting AP clinical trials since 2011, when he first joined UCSB as a graduate student.